Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Weisenseel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The British Journal of Dermatology|May 15, 2021
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trialD Thaçi, K Eyerich, A Pinter, et al.
Chemical Research in Toxicology|November 1, 1993
1H NMR of an oligodeoxynucleotide containing a propanodeoxyguanosine adduct positioned in a (CG)3 frameshift hotspot of Salmonella typhimurium hisD3052: Hoogsteen base-pairing at pH 5.8U S Singh, J G Moe, G R Reddy, et al.
Journal of Medical Genetics|October 4, 2002
Streptococcal infection distinguishes different types of psoriasisP Weisenseel, B Laumbacher, P Besgen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trialD Thaçi, A M Soliman, K Eyerich, et al.
Zeitschrift Fur Kardiologie|February 7, 1998
[Quantitative dobutamine stress echocardiography in follow-up of heart transplantation: normal values and findings in patients with transplant vasculopathy]C H Spes, V Klauss, H Mudra, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2023
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE studyK Schäkel, K Reich, K Asadullah, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The British Journal of Dermatology|May 15, 2021
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trialD Thaçi, K Eyerich, A Pinter, et al.
Chemical Research in Toxicology|November 1, 1993
1H NMR of an oligodeoxynucleotide containing a propanodeoxyguanosine adduct positioned in a (CG)3 frameshift hotspot of Salmonella typhimurium hisD3052: Hoogsteen base-pairing at pH 5.8U S Singh, J G Moe, G R Reddy, et al.
Journal of Medical Genetics|October 4, 2002
Streptococcal infection distinguishes different types of psoriasisP Weisenseel, B Laumbacher, P Besgen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trialD Thaçi, A M Soliman, K Eyerich, et al.
Zeitschrift Fur Kardiologie|February 7, 1998
[Quantitative dobutamine stress echocardiography in follow-up of heart transplantation: normal values and findings in patients with transplant vasculopathy]C H Spes, V Klauss, H Mudra, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2023
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE studyK Schäkel, K Reich, K Asadullah, et al.
Pageof 3